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Adenocarcinoma of the lung in Chinese patients: a
revisit and some perspectives from the literature
B Lam, W K Lam, C L Lam, G C Ooi, J C M Ho, M P Wong, K W Tsang
Abstract
Aim—To establish an updated clinical
profile of adenocarcinoma of the lung.
Design—Retrospective review of clinical
charts, chest radiography, and computed
tomography of consecutive patients who
attended Queen Mary Hospital in Hong
Kong between June 1995 and December
1997.
Results—In the 115 patients studied, 13%
were <40 years of age (33.3% ever smok-
ers). Haemoptysis is more common
among patients with early disease, while
finger clubbing was detected more com-
monly among smokers and ex-smokers.
Most (98.3%) patients had abnormal chest
radiology including presence of mass
lesion, pleural eVusion, collapse/
consolidation, and eVusion. Patients with
adenocarcinoma were significantly more
likely to be younger, female, in advanced
disease (stage IIIB and IV), non-smoker,
and symptomatic on presentation
(p<0.05) than those with squamous cell
lung cancer (n=128).
Conclusion—The clinical profile of Chi-
nese adenocarcinoma patients should help
clinicians in the diagnosis and manage-
ment of these patients.
(Postgrad Med J 2001;77:708–712)
Keywords: lung cancer; adenocarcinoma; clinical pro-
files
Lung cancer is the commonest lethal malig-
nant disease worldwide and many cases are
already at advanced stage on presentation.1 2
Despite considerable medical advances, the
five year survival for patients with lung cancer
is merely 14%.2 In Hong Kong, lung cancer
accounts for more than 40% of all cancer
deaths, and is the commonest lethal cancer in
both genders. Adenocarcinoma has surpassed
squamous cell carcinoma as the commonest
histological type of lung cancer in many locali-
ties including Hong Kong.3–6 Since the estab-
lishment of the Hong Kong Cancer Registry in
1990, adenocarcinoma has been consistently
found to be the commonest histological lung
cancer type, and has accounted for 30% of
newly diagnosed lung cancer from 1990 to
1996. Although there have been some pub-
lished series on the clinical profiles of patients
with lung cancer over the last three decades,7–9
few recent studies had addressed this increas-
ingly important and common type of lung can-
cer in a systematic manner. We have, therefore,
performed this review on Chinese patients with
adenocarcinoma of the lung in Hong Kong. We
aimed to establish an updated clinical profile of
this disease with particular emphasis on
presentation, symptomatology, and clinical
staging, and compare these characteristics with
patients with squamous cell lung carcinoma.
Our experience with this series of patients
should help clinicians have further insights into
the clinical characteristics of those with adeno-
carcinoma of the lung.
Methods
SUBJECTS
The clinical charts, chest radiographs, and
(whenever available) thoracic computed tom-
ography of all patients with a final diagnosis of
adenocarcinoma of the lung admitted to the
Department of Medicine of the University of
Hong Kong, between June 1995 and Decem-
ber 1997, were reviewed. Our institution is the
largest teaching hospital in Hong Kong SAR
and is a tertiary referral centre for all
respiratory diseases including lung cancer.
Inclusion criteria included histological or cyto-
logical evidence of adenocarcinoma of the lung
and fulfilment of other diagnostic criteria.4
These included the presence of the following:
compatible plain chest radiograph and/or
thoracic computed tomography; clinical fea-
tures of bronchial carcinoma including appro-
priate symptoms and signs; compatible clinical
or radiological metastatic lesions with or with-
out cytological or histological evidence; and
absence of other known malignancies or
diseases that would otherwise explain the over-
all clinical picture. The presence of a possible
non-pulmonary primary adenocarcinoma was
excluded in each case by detailed symptomatic
inquiry, full physical examination (including
breast examination for women, testicular
examination for men, and rectal examination),
and appropriate investigations in the presence
of appropriate systemic symptoms (including
gastroscopy, colonoscopy, abdominal and pel-
vic ultrasound or computed tomography, and
thyroid isotope scan).
CLINICAL FEATURES
Relevant clinical data were extracted from the
charts of eligible patients. These included
smoking history, presenting symptoms; pres-
ence or otherwise of constitutional symptoms
(weight loss, lethargy, and malaise), respiratory
symptoms including persistent cough (defined
as daily coughing for more than week weeks),
sputum production, haemoptysis, dyspnoea,
chest pain, recurrent or unresolved pneumo-
nia, hoarseness of voice, neck masses, bone
pain, or other systemic symptoms. The abnor-
mal signs found on initial physical examination
of the respiratory and other systems were also
recorded.
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RADIOLOGICAL FEATURES
The presenting chest radiographs and thoracic
computed tomography were reviewed by one
specialist thoracic radiologist (GCO) and the
abnormalities were specified as follows: nor-
mal, mass lesion, collapse and/or consolidation,
pleural eVusion, pneumothorax, lymph nodes,
and intrapulmonary or bone metastasis.
OTHER ASSESSMENTS
Since April 1978 flexible fibreoptic bronchos-
copy had been a routine diagnostic procedure
for suspected cases of lung cancer in our insti-
tution. The tumour was classified according to
whether or not it was macroscopically visible at
bronchoscopy. One specialist pathologist
(MPW), according to standard World Health
Organisation classification,4 reviewed all histo-
logical and cytological specimens. The TNM
(tumour, node, and metastasis) staging of the
lung cancer was determined by the combined
information obtained through detailed clinical
examination, skeletal imaging, ultrasound
scanning, lymph node or other tissue biopsy,
and contrast computed tomography using
standard criteria.11
DATA ANALYSIS
Summary statistics of the presenting clinical
and radiographic features were obtained by
cross tabulations. Ex-smokers were reclassified
as smokers. Patients were arbitrarily classified
as “young” if their age at presentation was 40
years or less, and as “early” presenters if the
TMN staging was II or less. Comparison of
data between groups of patients was by ÷2 tests,
Fisher’s exact tests, and Mann-Whitney U test
where appropriate. Where appropriate statisti-
cal analysis was performed to determined if
“early” presenters of the disease would be
identified on the basis of information obtained
at presentation. A p value of <0.05 was taken as
indicative of statistical significance. The analy-
sis was performed using the Statistical Analysis
System package.
Results
SUBJECTS WITH ADENOCARCINOMA
From June 1995 to December 1997, a total of
354 consecutive new cases of primary cancer of
the lung were diagnosed in our centre. Of
these, 115, 128, 12, 74, and 25 patients were
histologically classified as adenocarcinoma,
squamous cell, large cell, non-small cell, and
small cell lung cancer. Among the patients with
adenocarcinoma of the lung, there were 40
women and the median (range) age of the
cohort was 58 (22–87) years. A previous or
current history of cigarette smoking was
present in 64 (55.7%) patients of whom eight
were women and 34 were current smokers. Fif-
teen (13.0%) patients were aged 40 years or
less at the time of presentation. Based on the
TNM classification, there were one (0.9%),
five (4.3%), five (4.3%), 31 (27.0%), and 73
(63.5%) patients who had stage I, II, IIIA, IIIB,
and IV disease at diagnosis respectively. There
were therefore only six (5.2%) patients who
presented with “early” disease, namely TMN
stage II or less. The youngest patient was a
women who had never smoked, who was 22
years of age on presentation with stage IV dis-
ease.
PRESENTING FEATURES OF ADENOCARCINOMA
The presenting features of these patients are
summarised in table 1. Five patients were
entirely asymptomatic at time of presentation
and were found to have abnormal lesions on
incidental chest radiographs. All these five
patients had unresectable (TNM stages IIIB or
IV) disease. Thirty seven, 47, and 25 patients
had one, two, and three or more symptoms at
presentation respectively. The commonest pre-
senting symptoms were persistent cough,
haemoptysis, malaise, and weight loss. Weight
loss was a common presenting feature (28.7%)
but it occurred largely in association with other
symptoms and was, therefore, not a specific
indicator of disease. Persistent cough and hae-
moptysis were the sole presenting symptoms in
10 (8.7%) and seven (6.1%) cases. Together,
these symptoms were present in 74 (64.3%) of
cases. The mean duration of symptoms before
presentation was 80 (range 1–730) days.
Haemoptysis occurred significantly more com-
monly in those who were considered as “early”
presenters (TMN stage II or lower) than the
“late” presenters (p<0.001). There was no sig-
nificant diVerence in the other presenting
features or findings between those who were
“early” and “late” presenters.
The physical findings on initial presentation
are summarised in table 1. Twenty five (21.7%)
cases did not have abnormal physical signs at
the time of presentation. Of these, 89.3% of
cases had advanced (TNM stage IIIB or IV)
diseases. Among those in whom physical signs
were found, pleural eVusion, cervical lymph
nodes, finger clubbing, and pulmonary
collapse/consolidation were among the most
common. Pleural eVusion and cervical lym-
phadenopathy were the sole presenting find-
ings in 17 (14.8%) and six (5.2%) cases
respectively. Finger clubbing was more
Table 1 Clinical symptoms at presentation in patients
with adenocarcinoma of the lung
Presenting features
No (%)
patients
Mean duration
(days)
Symptoms
Asymptomatic 5 (4.3) —
Persistent cough 56 (48.7) 66.6
Haemoptysis 35 (30.4) 106.0
Malaise and weight loss 33 (28.7) 58.2
Dyspnoea 29 (25.2) 42.3
Chest pain 21 (18.3) 74.9
Neurological 9 (7.8) 47.2
Bone pain 8 (7.0) 38.5
Hoarseness 7 (6.1) 25.9
Neck mass 5 (4.3) 82.2
Unresolved pneumonia 2 (1.7) 2.0
Miscellaneous 8 (7.0) 49.0
Signs
Normal 25 (21.7) —
Pleural eVusion 37 (32.2) —
Cervical lymph node 30 (26.1) —
Clubbing/HPO 20 (17.4) —
Collapse/consolidation 17 (14.8) —
Hepatomegaly 8 (7.0) —
Neurological 7 (6.1) —
Superior vena cava
obstruction
5 (4.3) —
Others 6 (5.2) —
HPO = hypertrophic pulmonary osteoarthropathy.
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commonly found among previous or current
smokers than those who had never smoked
(p<0.005). Taken together, other than haemo-
ptysis, there was no particular pattern of
presenting symptoms, physical signs, and
imaging findings that would distinguish be-
tween the “early” from the “late” presenters.
There was no significant diVerence in the pre-
senting symptoms between adenocarcinoma
patients who were never or ever smokers
(p>0.05, table 2).
OTHER INVESTIGATIONS IN ADENOCARCINOMA
Chest radiographs and computed tomography
were available for review in 113 and 73 patients
respectively (table 3). The commonest abnor-
mality at presentation was a mass lesion,
followed by pleural eVusion. Computed tom-
ography had positively identified a greater per-
centage of lesions compared with the chest
radiographs (table 3). Diagnostic bronchos-
copy was performed on 69 patients in whom 54
(78.3%) showed centrally located, that is, mac-
roscopically visible, tumours. Concomitant
presence of pleural eVusion and abnormal cer-
vical lymph nodes occurred in 58 (50.4%)
cases.
Discussion
In this study, 13% of our adenocarcinoma
patients were younger than 40 years of age on
presentation and only 33.3% of these had ever
smoked. Most of the female patients (80%)
had never smoked. The presence of persistent
cough and haemoptysis occurred in 64.3% of
patients. Most patients had mass lesion or
pleural eVusion on the presenting chest radio-
graph. There were significantly more patients
presenting with haemoptysis in early disease
(TNM less than II) compared with more
advanced TNM staging (p<0.001). Finger
clubbing was found significantly more com-
monly among patients who had been smokers
(p<0.005). However, there was no significant
diVerence in the presenting features, physical
or imaging findings between those who were 40
years or younger and those who were over 40.
Unfortunately, all the patients who had adeno-
carcinoma diagnosed from incidental chest
radiographs had advanced diseases as had the
majority (89.3%) of cases who had a normal
physical examination.
Most Western studies have consistently
showed a low incidence of lung cancer in non-
smokers and young subjects less than 40–50
years of age.12–14 However, our results show a
preponderance of young female adenocarci-
noma patients who have never smoked (table
2). This directly contrasts the results reported
by the Edinburgh Lung Cancer Group, which
reported that only 2% of 3070 patients had
never smoked.14 The Edinburgh study also
reported that non-smoking patients with lung
cancers (predominantly adenocarcinoma) were
significantly older than their counterparts
(75.4 v 68.0 years),14 although there was no
such significant age diVerence in our adenocar-
cinoma patients (54 v 60 years; table 2). In fact,
our patients with adenocarcinoma were signifi-
cantly younger than their counterparts who
had squamous cell lung cancer (58 v 69 years;
table 2). There are also another nine studies,
conducted in the 1960s and 1970s, on
non-smoking Caucasian patients who had lung
cancer.14–22 These showed that adenocarci-
noma, squamous cell and small cell lung
cancers accounted for 31%–69%, 6%–32%,
7%–42% of all lung cancer types respectively.
The characteristics of patients in the aforemen-
tioned studies do not correspond with those of
the Chinese patients. A recent pathological
survey in Hong Kong, which was not accompa-
nied with analysis on clinical and radiological
features, showed that adenocarcinoma ac-
counted for 37.3% of all lung cancers and 50%
of these cases were under 40 years of age.6
Although the association between smoking
and lung cancer has been well established,23 a
higher proportion of the patients with bron-
chial adenocarcinoma are non-smokers.14–22
The smoking rates for the general population in
Table 2 Comparison of clinical features between adenocarcinoma and squamous cell lung cancer
Adenocarcinoma Squamous cell
All
(n=115)
Never smoker
(n=51)
Ever smoker
(n=64)
All
(n=128)
Never smoker
(n=19)
Ever smoker
(n=109)
Median age (range) in years 58 (22–87)* 54 (22–87) 60 (37–84) 69 (42–88) 67 (42–81) 69 (42–88)
No of patients (% of patients)
Female 40 (34.8)* 34 (66.7)† 6 (9.4) 23 (18.0) 9 (47.3)† 14 (12.8)
Stage IIIB/IV disease 105 (91.3)* 47 (92.1) 58 (90.6) 96 (75) 16 (84.2) 80 (73.4)
No of patients with symptoms (% of patients)
Asymptomatic 5 (4.3)* 1 (0.02)* 4 (6.3)* 22 (17.2) 4 (21.1) 18 (16.5)
Persistent cough 56 (48.7) 27 (25.9) 29 (45.3) 66 (51.6) 8 (42.1) 58 (53.2)
Haemoptysis 34 (29.6) 14 (27.4) 20 (31.3) 30 (23.4) 3 (15.8) 27 (24.8)
Malaise and weight loss 33 (28.7) 17 (33.3) 16 (25) 26 (20.3) 5 (26.3) 21 (16.4)
Dyspnoea 29 (25.2) 15 (29.4) 14 (21.9) 40 (31.3) 4 (21.1) 36 (33.0)
Chest pain 21 (18.3) 11 (21.6) 10 (15.6) 23 (18.0) 3 (15.8) 20 (18.3)
Hoarseness 7 (6.1) 1 (2.0) 6 (9.4) 6 (4.7) 1 (5.3) 5 (4.6)
Pleural involvement 37 (32.2) 21 (41.2) 16 (25) 29 (22.7) 6 (31.6) 23 (21.1)
*Indicates p<0.001 when compared data from corresponding patient group or subgroup with squamous cell lung cancer.
†Indicates p<0.001 when compared with smokers who had the same histological type of lung cancer.
Table 3 Imaging findings in 115 patients with adenocarcinoma of the lung
Finding
No (%) having
chest radiography
(n=113)
No (%) having
computed tomography
(n=73)
No of findings detected
only by computed
tomography
Normal 2 (1.7) 0 0
Mass 81 (71.9) 55 (75.3) 11
Pleural eVusion 45 (39.1) 28 (38.4) 7
Collapse/consolidation 18 (15.6) 18 (24.7) 11
Metastases 9 (7.8) 35 (47.9) 29
Mediastinal lymph node 7 (6.1) 39 (53.4) 34
Pneumothorax 2 (1.7) 3 (4.1) 2
710 Lam, Lam, Lam, et al
www.postgradmedj.com
 on 6 November 2006 pmj.bmjjournals.comDownloaded from 
Hong Kong were recently reported to be 2.9%
for women and 27.1% for men respectively.24
In this study, 43.9% of the adenocarcinoma
patients had never smoked and there were sig-
nificantly more women than men who had
never smoked (81.0% v 12.8%), although
there appears to be more female smokers in our
cohort than in the general population. The
high incidence of adenocarcinoma of the lung
among non-smoking young Chinese women in
Hong Kong also sharply contrasts that re-
ported from Europe and North America.14–22
The aetiological factors for the high incidence
of bronchial adenocarcinoma in women in
Hong Kong, who are largely non-smokers,
remain obscure.25 26 Studies of passive smoking
in Hong Kong have given inconsistent re-
sults,27 28 and studies on other environmental
inhaled agents such as fumes from kerosene
stoves and incense burners have also been
negative.29 Similarly, HLA antigen analysis and
genetic studies to date have not been able to
define the aetiological factors.30–36
The long duration of symptoms before diag-
nosis reflects a possible low index of suspicion
of lung cancer among doctors and also the
non-specific nature of many of the presenting
symptoms. This was probably also perpetuated
by the traditional clinical teaching of a remote
probability of lung cancer among non-smokers.
Although emergence of symptoms is usually
indicative of advanced disease status and poor
prognosis, carcinoma of the major bronchi
might present early. Abnormalities were found
in the presenting chest radiographs in 98.3% of
the patients. This suggests that, although not
being cost eVective as a screening tool, chest
radiography is a sensitive and cost eVective ini-
tial investigation for patients with suspected
disease. Our results therefore suggest that Chi-
nese patients, particularly women, irrespective
of their risk factor profiles, should undergo
intensive investigations to exclude lung cancer
in the presence of mass lesion, pleural eVusion,
or collapse/consolidation seen on chest radio-
graphy (table 2).
We have also compared the clinical profiles
of our patients with a concurrent cohort of
patients with squamous cell lung cancer
(n=128; 23 women; stages I, II, IIIA, IIIB, and
IV were 1.6%, 3.1%, 20.3%, 39.1%, and
35.9% respectively). Patients with adenocarci-
noma were significantly more likely to be
younger (p<0.0001), of female gender
(p=0.03), never smokers (p<0.001), in ad-
vanced disease, that is stage IIIB and IV
(p=0.001), but less likely to be asymptomatic
(p=0.001) when compared with their counter-
parts with squamous cell lung cancer (table 2).
There were, otherwise, no significant diVerence
in the presenting features for patients with
adenocarcinoma and squamous cell lung can-
cer (p>0.05). A previous history of smoking
was not associated with any significant diVer-
ence in the staging of lung cancer on presenta-
tion in both histological types of lung cancer
(p>0.05, table 2). Smokers with squamous cell
lung cancer were significantly more likely to be
asymptomatic at presentation than their coun-
terparts with adenocarcinoma (p=0.003, table
2), although there is no obvious explanation.
Adenocarcinoma of the lung is an increas-
ingly more prevalent lung malignancy and our
experience shows that it predominantly aVects
women who have never smoked and are symp-
tomatic on presentation with advanced disease.
Our explanation on this series of patients
should help clinicians in the evaluation of
patients, particularly Chinese females, with
lung cancer.
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Medical Anniversary
Sir William James Erasmus Wilson,
25 November 1809
Sir William James Erasmus Wilson (1809–
84) was born in Marylebone High Street,
London, the son of an Aberdeen naval
surgeon who settled as a surgeon in Dart-
ford, Kent. He was educated at Epsom
College and St Bartholomew’s (1831),
became a lecturer in anatomy and physiol-
ogy at the Middlesex Hospital, assistant
editor of the Lancet (1840), surgeon to St
Pancras Infirmary, FRS (1845), President
of the Medical Society of London (1878),
President of the Royal College of Surgeons
(1881), and was knighted in 1881.
He had a successful consulting practice
as a dermatologist; it was said that when he
entered a room those present would start
scratching themselves. His numerous ben-
efactions included restoring Swanscombe
church, rebuilding the headmaster’s house
at Epsom College, founding a scholarship at
the Royal College of Music, and endowing a
chair of dermatology at the Royal College of
Surgeons. He paid £10 000 to transport
Cleopatra’s Needle from Alexandria to the
Victoria Embankment, London and
£30 000 for a new wing and chapel to the
Margate Seabathing Infirmary.
He died at his home in Westgate on 7 August
1884 leaving £200 000 to the Royal College
of Surgeons.—D G James
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